ANTONIS MARKOU: Open Payments
NPI 1700262706 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,313 in 209 payments from 16 companies in 2025. Trend: 2023 $8,526 · 2024 $7,729 · 2025 $4,313
Food & beverage: $4,303Education: $10
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 11 | $539 |
| Incyte Corporation | 22 | $429 |
| ABBVIE INC. | 25 | $414 |
| Regeneron Healthcare Solutions, Inc. | 19 | $386 |
| Galderma Laboratories, L.P. | 13 | $382 |
| LEO Pharma Inc. | 17 | $370 |
| MAYNE PHARMA COMMERCIAL LLC | 32 | $343 |
| GENZYME CORPORATION | 14 | $323 |
| Arcutis Biotherapeutics, Inc. | 15 | $310 |
| Janssen Biotech, Inc. | 13 | $287 |
Products named: DUPIXENT, OPZELURA, SKYRIZI, NEMLUVIO, Zoryve, TREMFYA, ADBRY, VTAMA.
Industry payments across TX — which companies pay providers there.
